- Events
17/04/2025
TransCure bioServices is proud to announce our participation in the 7th Global MASLD Congress, to be held on June 24-25, 2024, at the London Heathrow Marriott. This essential gathering brings together the leading minds in the study of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic associated steatohepatitis (MASH), conditions that continue to challenge the medical community due to their complex pathogenesis and lack of approved pharmaceutical treatments.
The rising incidence of MASLD and MASH underscores the urgent need for innovative diagnostic and therapeutic approaches. The Global MASLD Congress is at the forefront of addressing these challenges, offering insights into promising clinical developments and novel diagnostic tools that are reshaping the landscape of liver disease treatment.
Join Ha-Yeon Kim-Penard, PhD, Scientist Business Developer, and Clothilde Philouze, PhD, R&D Project Leader, to learn about our latest advancements in preclinical humanized liver mouse models that are crucial for pre-clinical research in liver diseases. Our team is looking forward to engaging with peers, discussing potential collaborations, and exploring how our innovative solutions can support ongoing and future research projects.
Whether you are looking to advance your knowledge, showcase your latest research, or find partners for future collaborations, the Global MASLD Congress is an event not to be missed. We invite all stakeholders involved in liver disease research and treatment to join us at this significant event.
We look forward to welcoming you to London and joining hands in the fight against liver disease.
See you at the Global MASLD Congress 2024!